The Death of the "One-Size-Fits-All" Model: Why Your Legacy Strategy is a Strategic Liability

If you are a technology leader in the healthcare space, you are likely sitting on a mountain of data that is fundamentally lying to you. For decades, the industry has been built on the myth of the "average patient." We design trials for them, we code billing systems for them, and we build clinical workflows to treat them. But in the oncology ward, the average patient is a ghost. Every tumor is a unique, evolving data ecosystem, yet our legacy infrastructure still tries to force-feed these complexities into a standardized, "one-size-fits-all" pipe. As a decision-maker, continuing to invest in technology that supports this rigid, trial-and-error model isn't just a clinical oversight. It is a massive operational risk. We are entering an era where "Standard of Care" is no longer a fixed protocol, but a dynamic, data-driven response. If your roadmap is still centered on static databases and siloed genomic reports, you aren't building a future-proof system. You’re managing a depreciating ass